Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for acute headache in the ED
NCT03081416Phase 3Completed
- Sponsor
- Brooke Army Medical Center
- Start
- May 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketamine in Headache, sponsored by Brooke Army Medical Center. Primary endpoint: Visual Analogue Scale at 30 minutes. Started May 2016; status: completed.
02
Drugs
ketamine
03
Conditions
Headache
Beyond the preview
Go deeper on NCT03081416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081416.